Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Mar 1, 2016

5262_dirs_2016-03-01_88d5aa06-33fd-4615-b845-b3b3dc8568cd.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6674Q

GlaxoSmithKline PLC

01 March 2016

GlaxoSmithKline plc

Notification of Transactions of

Directors and Persons Discharging Managerial Responsibility

Vesting of conditional share awards made under

the GlaxoSmithKline Share Value Plan

This notification sets out the vesting of awards over Ordinary Shares made in 2013 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.

The restricted period for the 2013 SVP awards has now ended and the awards made to Persons Discharging Managerial Responsibility (PDMR) vested on 28 February 2016. Details are given in the table below.

Name of PDMR Number of Ordinary Shares vested Number of ADS  vested
Mr N Hirons* 5,740
Mrs V Whyte 13,070

* Mr Hirons was not a PDMR at the time of grant and has subsequently been appointed PDMR.

The Company and PDMRs were advised of these transactions on 29 February 2016.

The closing price of an Ordinary Share and of an ADS of GlaxoSmithKline plc on 26 February 2016, the business day prior to vesting, were £14.105 and US$39.14 respectively.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 March 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZFLFBQXFXBBZ